Cara Therapeutics trading halted, news pending
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 30 2024
0mins
Source: Business Insider
Trading Halt: Cara Therapeutics (CARA) has had its trading halted due to pending news.
Recent Developments: The company recently announced a 1-for-12 reverse stock split and is merging with Tvardi Therapeutics.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
